Navigation Links
arGEN-X Concludes EUR 12.5 Million Series A Financing Round
Date:12/3/2009

generate an optimal lead diversity.

Philippe Guinot, PhD, Senior Partner at Credit Agricole Private Equity commented: "We believe that arGEN-X has a truly innovative technology and a management team with an impressive track record of building a valuable business in the antibody area. It is no surprise to us that the Company was able to attract such a high-quality syndicate of investors for its Series A round and Credit Agricole Private Equity is delighted to have had this opportunity to participate at this important early stage of the arGEN-X' development."

Tim Van Hauwermeiren, Chief Executive Officer of arGEN-X added: "We are very pleased to have raised this additional funding from two experienced European life science investors. In addition, we are proud to become VIB's first external investment and we view this as a real quality stamp of approval. With substantial funding now in place, arGEN-X is well positioned to execute its ambitious value-creating strategy over the next two years."

Notes for the editor

About arGEN-X - http://www.arGEN-X.com

arGEN-X is a research stage biopharmaceutical company with a broadly applicable, proprietary SIMPLE Antibody(TM) platform. The platform allows arGEN-X to create an unparalleled diversity of in vivo generated antibody leads against a broad range of human disease targets. This superior choice of ultra-high affinity and highly potent leads, having best-in-class human homology, allows for more stringent lead selection criteria, thereby increasing the probability of success later in the drug development path. The Company has validated its monoclonal antibody platform on two human disease targets and has broad patent claims in place covering its technology.

arGEN-X(TM) and SIMPLE Antibody(TM) are deposited trademarks of arGEN-X BV.

SIMPLE stands for Superior Immuno
'/>"/>

SOURCE arGEN-X
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Phase IV Multi-center Clinical Study of Kutai Concludes in Nanjing
2. Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997
3. Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests
4. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
5. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
6. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
7. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
8. Russias Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013
9. For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult
10. Vermillion Files Plan of Reorganization
11. Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013 Fuse Science, Inc. (OTCQB: ... company that is developing new, patent-pending technologies poised to redefine ... that it will hold a business update teleconference and webcast ... nd , 2013 at 4:30 PM ET. ... will host the call and will be joined by ...
(Date:5/17/2013)... , May 17, 2013 ... developer of oral drug delivery systems, announced today that ... cleared the Company,s Investigational New Drug application(IND) for ORMD-0801, ... pleased to have the FDA clearance to proceed," stated ... "The upcoming trial is a major milestone for Oramed ...
(Date:5/16/2013)... 16, 2013  PTC Therapeutics, Inc., today announced that ... with the U.S. Securities and Exchange Commission ("SEC") relating ... stock. The number of shares to be offered and ... determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... joint book-running managers for the offering. Cowen and Company ...
Breaking Medicine Technology:Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... , Feb. 11 The American Academy of Pain ... Presidential Commendations and Awards presented by the Academy,s Immediate Past President, ... recipients were recognized at AAPM,s 26th Annual Meeting held in ... physicians convened to learn the latest in Pain Medicine. , ...
... , , CAMBRIDGE, Mass. , ... SHPGY ), the global specialty biopharmaceutical company, today presented positive ... and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy ... were presented in an oral presentation at the Lysosomal Disease ...
Cached Medicine Technology:The American Academy of Pain Medicine Announces this Year's Presidential Commendations and Awards 2The American Academy of Pain Medicine Announces this Year's Presidential Commendations and Awards 3The American Academy of Pain Medicine Announces this Year's Presidential Commendations and Awards 4Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease 2Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease 3Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease 4Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease 5Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease 6Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease 7
(Date:5/19/2013)... Dr. Keith Chertok now provides gum disease patients with a ... the chance of a healthier smile. Laser gum surgery ... only removes diseased gum tissue in patients, but it also ... dental implants. , LANAP uses a laser to successfully ... stimulate the healthy tissue as well as encourage new bone ...
(Date:5/19/2013)... Exciting new Skin Brushes are available from ... practice known through the ages but is a lost ... brushing, has so many benefits for our health and ... love that circulation and lymphatic systems get a boost ... is supported through Skin Brushing." , Why is Skin ...
(Date:5/19/2013)... 2013 HealthEconomics.Com , the global ... to unveil a new and exciting service: HE-Xpo: a ... powerful array of real-time communication tools to expand their ... abroad. , HE-Xpo is powered by OnStream Media’s ... and feel of being at a physical trade show, ...
(Date:5/18/2013)... Columbia (PRWEB) May 19, 2013 In “Cooking ... (published by iUniverse) , author Janet Hall Svisdahl’s new cookbook, ... recipes sure to make even the pickiest eater drool. ... pleasurably and prayerfully,” she explains. , Found within the ... a wide range of delicious recipes, from fast and simple ...
(Date:5/18/2013)... Angeles, California (PRWEB) May 18, 2013 ... surgery is an increasingly popular weight loss surgery that ... Lap Band Center wishes to give readers ... , Dr. Naim attended medical school at New York ... at New York Methodist he undertook a fellowship in ...
Breaking Medicine News(10 mins):Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:Everything You Need to Know About Lap Band Surgery 2Health News:Everything You Need to Know About Lap Band Surgery 3
... Ill. An automated system for measuring brain tissue ... accurately diagnose Alzheimer,s disease at an earlier stage according ... of the journal Radiology . , In Alzheimer,s ... areas of the brain, especially the hippocampus region, to ...
... Looms in Charlotte, Cincinnati,Cleveland, Dallas-Ft. Worth, Kansas City, ... ARLINGTON, Va., June 23 The American,Association ... competitive,bidding program for home medical equipment in order ... continuity of care for seniors and people,with disabilities. ...
... Than $150 Million in New Revenue for,Medicaid, WASHINGTON, ... to resolve a projected state budget deficit, a,report released ... would,raise more than $150 million in new revenue to ... smokers to quit, reduce,tobacco-related health care costs and save ...
... Benefit TAC, ARLINGTON, Va., June ... ,3066584/ref=pd_bbs_sr_1?ie=UTF8&s=books&qid=1213968063&sr=8-1 ), E. Fuller,Torrey, M.D.,s latest ... the greatest social,disasters in recent American ... hundreds,of thousands of patients with severe ...
... cost may still be prohibitive, experts say , , MONDAY, June ... deposits accurately predicts the overall death risk for American adults, ... best predictor we have of who will have a problem ... associate professor of medicine at the Harbor-UCLA Medical Center. , ...
... China, June 23 /Xinhua-PRNewswire/ -- China Medicine,Corporation ... "the Company"),a leading distributor and developer of ... nutritional and dietary supplements,medical devices, and medical ... today announced it has successfully obtained the ...
Cached Medicine News:Health News:Automated MRI technique assists in earlier Alzheimer's diagnosis 2Health News:American Association for Homecare Recommends Needed Improvements to Medicare Competitive Bidding Program, Set to Begin July 1 2Health News:American Association for Homecare Recommends Needed Improvements to Medicare Competitive Bidding Program, Set to Begin July 1 3Health News:New Report: Increasing Mississippi's Cigarette Tax Will Reduce Smoking, Save Lives and Save Money 2Health News:Dr. Torrey Takes 'The Insanity Offense' 2Health News:Arterial Calcium Scans Can Predict Death Risk 2Health News:Arterial Calcium Scans Can Predict Death Risk 3Health News:Arterial Calcium Scans Can Predict Death Risk 4Health News:China Medicine Maintains Exclusive Rights to Distribute 2,300 Pharmaceutical Products 2Health News:China Medicine Maintains Exclusive Rights to Distribute 2,300 Pharmaceutical Products 3
Features four-way apron closure for super adjustability to fit staff of all shapes and sizes. Top left and right shoulder closures allow adjustment of armhole size and chest area of apron for close a...
Freedom of movement - plus full circle, maximum radiation protection. No other full circle radiation protection design approaches the level of comfort of the VestSkirt, which divides weight between t...
Use this workhorse apron where 360 of protection from direct and scatter radiation is required....
Bio-Rad's Genetic Systems™ HBsAg EIA 3.0 screening and confirmatory assays offer outstanding sensitivity and early detection of HBV infection, helping to meet your testing criteria....
Medicine Products: